Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 20, 2020Journal of Diabetes InvestigationOpen Access

The optimal cut-off point of BMI for sarcopenia risk was 24.4 kg/m2 (AUC 0.729, 95% CI 0.688–0.770), which did not significantly differ from gait speed (P = 0.09).

View Full Paper
Ask AI
Bookmark
Share

Why the study?

This study examined the association between body mass index and the risk of sarcopenia in Japanese type 2 diabetes patients.

Is body mass index equivalent to slow gait speed for diagnosing sarcopenia in Japanese individuals with type 2 diabetes?

Population

1,137 Japanese type 2 diabetes outpatients

Comparison

Body mass index vs gait speed

Design

Cross-sectional study

Authors

SNShuhei NakanishiMIMasahiro IwamotoHSHisanori Shinohara

Discussion

Loading...

Member takes

Overview

May support BMI-based sarcopenia screening in type 2 diabetes; leaves open causal links and outcome impact.

Structured PICO

Is body mass index equivalent to slow gait speed for diagnosing sarcopenia in Japanese individuals with type 2 diabetes?

P
Population
1,137 Japanese patients with type 2 diabetes visiting an outpatient clinic
I
Intervention
Body mass index (BMI)
C
Comparator
Gait speed
O
Outcome
Presence of sarcopenia (defined by Asian Working Group for Sarcopenia 2014)surrogate

A BMI <24 kg/m2 in Japanese patients with type 2 diabetes is associated with an increased risk of sarcopenia, with diagnostic performance equivalent to slow gait speed.

Limitations

  • Further prospective investigation is required

Cite This Study

Nakanishi et al. (2020) studied this question.

synapsesocial.com/papers/6a869bb6c85029ed8c0cfa48https://doi.org/10.1111/jdi.13366
View Full Paper
Ask AI
Bookmark
Share